Our approach
Powerful platforms such as AI-assisted drug design and high-throughput screening, combined across disciplines to build a new paradigm for drug discovery.
Explore our approach
R&D
Novel medicines for major human diseases
Building on the research base of Westlake University and Westlake Laboratory, Westlake Pharmaceuticals integrates artificial intelligence, DNA-encoded library (DEL) screening, structural biology and medicinal chemistry to discover original small-molecule drugs against cancer and viral disease.
Pipeline
Small-molecule targeted therapies, with a focus on oncology and viral disease.
See the full pipeline
Platforms decide what we can see; the pipeline records how far we have come. Our 11 programmes cover 7 development stages from drug discovery to market, and Mprosevir® became the first approved medicine of the portfolio in July 2026.